1. Home
  2. ACON vs LRHC Comparison

ACON vs LRHC Comparison

Compare ACON & LRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACON
  • LRHC
  • Stock Information
  • Founded
  • ACON 2008
  • LRHC 2004
  • Country
  • ACON United States
  • LRHC United States
  • Employees
  • ACON N/A
  • LRHC N/A
  • Industry
  • ACON Retail: Computer Software & Peripheral Equipment
  • LRHC
  • Sector
  • ACON Technology
  • LRHC
  • Exchange
  • ACON Nasdaq
  • LRHC Nasdaq
  • Market Cap
  • ACON 4.8M
  • LRHC 5.4M
  • IPO Year
  • ACON 2022
  • LRHC 2023
  • Fundamental
  • Price
  • ACON $6.48
  • LRHC $0.13
  • Analyst Decision
  • ACON Buy
  • LRHC
  • Analyst Count
  • ACON 2
  • LRHC 0
  • Target Price
  • ACON $481.00
  • LRHC N/A
  • AVG Volume (30 Days)
  • ACON 18.4K
  • LRHC 5.4M
  • Earning Date
  • ACON 05-15-2025
  • LRHC 05-29-2025
  • Dividend Yield
  • ACON N/A
  • LRHC N/A
  • EPS Growth
  • ACON N/A
  • LRHC N/A
  • EPS
  • ACON N/A
  • LRHC N/A
  • Revenue
  • ACON $54,601.00
  • LRHC $73,874,281.00
  • Revenue This Year
  • ACON $212.31
  • LRHC N/A
  • Revenue Next Year
  • ACON N/A
  • LRHC N/A
  • P/E Ratio
  • ACON N/A
  • LRHC N/A
  • Revenue Growth
  • ACON N/A
  • LRHC 90.36
  • 52 Week Low
  • ACON $6.20
  • LRHC $0.09
  • 52 Week High
  • ACON $3,499.51
  • LRHC $3.36
  • Technical
  • Relative Strength Index (RSI)
  • ACON 34.00
  • LRHC 41.00
  • Support Level
  • ACON $6.50
  • LRHC $0.14
  • Resistance Level
  • ACON $7.18
  • LRHC $0.15
  • Average True Range (ATR)
  • ACON 0.37
  • LRHC 0.02
  • MACD
  • ACON 1.22
  • LRHC 0.00
  • Stochastic Oscillator
  • ACON 14.50
  • LRHC 27.55

About ACON Aclarion Inc.

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.

About LRHC La Rosa Holdings Corp.

La Rosa Holdings Corp operates in the U.S. residential real estate market. It is a holding company for agent-centric, technology-integrated, cloud-based, multi-service real estate companies. The company's business is organized based on the services it provides internally to the agents and to the public, which are residential and commercial real estate brokerage, franchising, real estate brokerage education and coaching, and property management. The company has six reportable segments, namely: Real Estate Brokerage Services (Residential), Franchising Services, Coaching Services, Property Management, Real Estate Brokerage Services (Commercial), and Title Settlement and Insurance. It derives maximum revenue from the Real Estate Brokerage Services (Residential) segment.

Share on Social Networks: